507 related articles for article (PubMed ID: 12610102)
1. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
[TBL] [Abstract][Full Text] [Related]
2. Expression of HER2 and its association with AP-2 in breast cancer.
Pellikainen J; Naukkarinen A; Ropponen K; Rummukainen J; Kataja V; Kellokoski J; Eskelinen M; Kosma VM
Eur J Cancer; 2004 Jul; 40(10):1485-95. PubMed ID: 15196531
[TBL] [Abstract][Full Text] [Related]
3. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
[TBL] [Abstract][Full Text] [Related]
4. Expression of the cell cycle regulatory proteins p34cdc2, p21waf1, and p53 in node negative invasive ductal breast carcinoma.
Kourea HP; Koutras AK; Scopa CD; Marangos MN; Tzoracoeleftherakis E; Koukouras D; Kalofonos HP
Mol Pathol; 2003 Dec; 56(6):328-35. PubMed ID: 14645695
[TBL] [Abstract][Full Text] [Related]
5. p21/WAF1/Cip1 expression in invasive ductal breast carcinoma: relationship to p53, proliferation rate, and survival at 5 years.
Domagala W; Welcker M; Chosia M; Karbowniczek M; Harezga B; Bartkova J; Bartek J; Osborn M
Virchows Arch; 2001 Aug; 439(2):132-40. PubMed ID: 11561753
[TBL] [Abstract][Full Text] [Related]
6. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
7. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
[TBL] [Abstract][Full Text] [Related]
8. [Significance and expression of p53, p21(Cip1/WAF1) and Gadd45α in breast neoplasm tissues].
Gao QZ; Fei BJ; Qi XW; Pu Y; Feng YZ
Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(34):2389-93. PubMed ID: 23158659
[TBL] [Abstract][Full Text] [Related]
9. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
Anttila MA; Kosma VM; Hongxiu J; Puolakka J; Juhola M; Saarikoski S; Syrjänen K
Br J Cancer; 1999 Apr; 79(11-12):1870-8. PubMed ID: 10206307
[TBL] [Abstract][Full Text] [Related]
10. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma.
Rey MJ; Fernández PL; Jares P; Muñoz M; Nadal A; Peiró N; Nayach I; Mallofré C; Muntané J; Campo E; Estapé J; Cardesa A
J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378
[TBL] [Abstract][Full Text] [Related]
11. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
[TBL] [Abstract][Full Text] [Related]
12. Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.
Liu XP; Tsushimi K; Tsushimi M; Kawauchi S; Oga A; Furuya T; Sasaki K
Cancer Lett; 2001 Sep; 170(2):183-9. PubMed ID: 11463497
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.
Salvesen HB; Iversen OE; Akslen LA
J Clin Oncol; 1999 May; 17(5):1382-90. PubMed ID: 10334522
[TBL] [Abstract][Full Text] [Related]
15. P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis.
Pasz-Walczak G; Kordek R; Faflik M
Pathol Res Pract; 2001; 197(10):683-9. PubMed ID: 11700890
[TBL] [Abstract][Full Text] [Related]
16. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer.
Korkolopoulou P; Konstantinidou AE; Thomas-Tsagli E; Christodoulou P; Kapralos P; Davaris P
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):285-92. PubMed ID: 11127920
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
19. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of p21(WAF1) and p53 expression in breast carcinoma: an immunohistochemical study in 261 patients with long-term follow-up.
Caffo O; Doglioni C; Veronese S; Bonzanini M; Marchetti A; Buttitta F; Fina P; Leek R; Morelli L; Palma PD; Harris AL; Barbareschi M
Clin Cancer Res; 1996 Sep; 2(9):1591-9. PubMed ID: 9816338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
